NASDAQ:VKTX

Viking Therapeutics Stock Predictions

etoro logo Buy VKTX
*Your capital is at risk
$29.33
+0.0400 (+0.137%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

VKTX Prediction Chart

VKTX Predictions History

Latest community submissions for VKTX.
Predictor Target Session Target Price Result Direction Accuracy Score
Mar 8, 2024 $77.52 +4.76% $71.78 X 92.00% 0
Mar 8, 2024 $76.20 +2.97% $71.78 X 93.84% 0
Mar 8, 2024 Bullish $71.78 X 0
AlexVel AlexVel Pro
Mar 4, 2024 $82.55 -3.13% $91.34 X 90.38% 0
AlexVel AlexVel Pro
Mar 1, 2024 $76.87 -0.23% $85.22 X 90.20% 0
Feb 29, 2024 $92.86 -1.74% $77.05 V 79.48% 1
Feb 29, 2024 $91.88 -2.78% $77.05 V 80.76% 1
JS JS Pro
Feb 28, 2024 $78.37 -7.85% $94.50 X 82.93% 0
Feb 28, 2024 $83.56 -1.75% $94.50 X 88.42% 0
Feb 28, 2024 $82.67 -2.80% $94.50 X 87.48% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for VKTX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT VIKING THERAPEUTICS
Viking Therapeutics
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. It also dev...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE